{
    "code": "01050876",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01050876",
    "time": "2019-07-05 03:18:27",
    "許可證字號": "衛署藥製字第050876號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/09\/09",
    "發證日期": "98\/09\/09",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00105087606",
    "中文品名": "達普頌錠劑 100 毫克",
    "英文品名": "Exdapsone Tablets 100 mg",
    "適應症": "麻瘋病",
    "劑型": "110錠劑",
    "包裝": "2-1000 錠塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": "DAPSONE",
    "主製造廠": {
        "申請商名稱": "0939101200  科進製藥科技股份有限公司",
        "申請商地址": "台北市南港區園區街3號14樓之7",
        "主製造廠": "",
        "製造廠名稱": "6133050732  科進製藥科技股份有限公司新竹廠"
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0826000300",
            "成分名稱": "DAPSONE",
            "含量描述": "",
            "含量": "100.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Exdapsone Tablets 100mg Chinese PI_20151130-106-06-27(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01050876&Seq=003&Type=9"
        },
        {
            "title": "Exdapsone Tablets 100 mg_label-104-12-11(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01050876&Seq=002&Type=8"
        }
    ]
}